bpc-157 brain fog Is (Body Protection Compound 157) associated with as a side effect? BPC-157: Why Women Are Asking

All products are supplied strictly as laboratory research reagents and are not for human consumption

AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list

Typical Concentrations Referenced in Research Literature Published preclinical literature on the individual components provides concentration reference points

CS: Methodology, Writing review and editing, Investigation

Case Presentation A 34-year-old male, recently using heroin and tobacco, visited an emergency department (ED) due to severe left leg pain, swelling, and tenderness (Figure 3)